Cardiopulmonary Corp. Receives Additional FDA 510(k) Class II Clearance Broadening Bernoulli(R) Enterprise's Indications for Use With Medical Devices MILFORD, Conn., Oct. 13, 2009 (GLOBE NEWSWIRE) -- Cardiopulmonary Corp. ("CPC"), the developer of Bernoulli(R) Enterprise, has received an additional FDA 510(k) Class II clearance broadening...